- Report
- March 2024
- 191 Pages
Global
From €3277EUR$3,374USD£2,827GBP
€3641EUR$3,749USD£3,141GBP
- Report
- March 2024
- 180 Pages
Global
From €5779EUR$5,950USD£4,985GBP
- Report
- February 2024
- 182 Pages
Global
From €4759EUR$4,900USD£4,106GBP
- Report
- October 2023
- 146 Pages
Global
From €3426EUR$3,528USD£2,956GBP
€4031EUR$4,150USD£3,477GBP
- Report
- March 2022
- 124 Pages
Global
From €4322EUR$4,450USD£3,729GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €923EUR$950USD£796GBP
- Report
- March 2022
Global
From €4711EUR$4,850USD£4,064GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €923EUR$950USD£796GBP
The Cortisol Test is a type of In Vitro Diagnostic (IVD) used to measure the amount of cortisol in a patient's blood or urine. Cortisol is a hormone produced by the adrenal glands and is involved in the body's response to stress. Abnormal levels of cortisol can indicate a variety of medical conditions, including Cushing's syndrome, Addison's disease, and adrenal insufficiency. The Cortisol Test is used to diagnose these conditions, as well as to monitor the effectiveness of treatments.
The Cortisol Test market is a subset of the larger IVD market, which is estimated to be worth billions of dollars. The Cortisol Test market is expected to grow in the coming years due to the increasing prevalence of medical conditions associated with abnormal cortisol levels.
Some companies in the Cortisol Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more
